Research Summaries

disease development
disease development
11/14/2022
Researchers performed a systematic review and meta-analyses to better understand the relationship between antihypertensive agent use and the risk of Alzheimer disease development.
11/14/2022
Testing
Testing
10/20/2022
The researchers sought to determine a test that would adequately differentiate patients with dementia with Lewy bodies and Alzheimer disease.
10/20/2022
Comorbid conditions
Comorbid conditions
09/26/2022
This COVID-19 roundup discusses the risk of new onset Alzheimer disease, vascular events, and atrial fibrillation after COVID-19 infection, and the impact of vaccination against COVID-19 in individuals on...
09/26/2022
Advances
Advances
08/23/2022
Researchers recently revealed findings in 3 new clinical trials at the Alzheimer’s Association International Conference 2022, including interventions that slowed cognitive decline, and interim results of a...
08/23/2022
Advances
Advances
08/23/2022
Researchers recently revealed findings in 3 new clinical trials at the Alzheimer’s Association International Conference 2022, including interventions that slowed cognitive decline, and interim results of a...
08/23/2022
Advances
Advances
08/23/2022
Researchers recently revealed findings in 3 new clinical trials at the Alzheimer’s Association International Conference 2022, including interventions that slowed cognitive decline, and interim results of a...
08/23/2022
Vaccination
Vaccination
07/14/2022
Researchers examined the relationship between influenza vaccination and the development of Alzheimer disease in older US adults.
07/14/2022
Vaccination
Vaccination
07/14/2022
Researchers examined the relationship between influenza vaccination and the development of Alzheimer disease in older US adults.
07/14/2022
Gastrointestinal Disorders
Gastrointestinal Disorders
05/24/2021
In a recent study, researchers investigated the association between rates of Alzheimer disease and inflammatory bowel disease.
05/24/2021
Treatment
Treatment
03/15/2021
The authors of a recent study aimed to examine if the antibody donanemab could improve Alzheimer disease by targeting amyloid deposits.
03/15/2021